Chuan Lin – Chairman, TTY Biopharm, Taiwan
Chuan Lin, chairman of TTY Biopharm, one of Taiwan’s leading domestic biomedical players, highlights his ambition to lead the local success story onto the global stage. Chuan goes on to…
EY is a global leader in professional services, employing 167,000 people in 150 countries and 728 offices around the globe. Their global revenues amounted to US$24.4 billion in financial year 2012. Apart from auditing services, EY also provides advisory services including tax advisory, transaction advisory, internal control, risk management, information technology security, performance improvement and corporate governance, etc. They are recognized for “delivering value” to their clients in different service areas. In 2012, they provided audit, risk management, tax and other advisory services to 80 percent and 63 percent of Fortune Global 500 and Forbes Global 2000 companies, respectively. Their strategy is to use their global professional talent and knowledge to assist their clients to tackle challenges in an ever-changing market environment.
EY Taiwan was established as the first partnership accounting firm in Taiwan, and is an official member of EY. They employ 1,200 professionals across Taiwan by creating the right team in the right place, and provide clients with multi-disciplinary assurance, business advisory, tax and transaction advisory services. Their main office is located in Taipei, with five branch offices in Chungli, Hsinchu, Taichung, Tainan, and Kaohsiung. They have joined EY in China and Hong Kong in forming the Greater China Area to provide clients with comprehensive and efficient services by leveraging their knowledge base and integrated network.
Contact details
Assurance
Based on legitimate professional standards, their assurance, financial report audit, and other value added services assist companies to improve effectiveness and quality.
Assurance Services Leader: Kim Chang / +886-2-2757-8888 #2317
Tax
They help companies navigate the latest tax policies, provide tax assessment and diagnosis, and address potential tax risks.
Tax Services Leader: Heidi Liu / 886-2-2757-8888 #2705
Transactions
They assist clients to evaluate, negotiate, structure, and succeed in transactions by seizing market opportunities to sustain advantageous position and boost growth.
Transaction Advisory Services Managing Director: Jonathan Hsin / +886-2-2757-8888 #1527
Advisory
When major issues strike, their approach helps organizations reduce risks, improve performance, overcome the internal and external challenges, and maximize profits.
Advisory Services Managing Director: Tony Chang / +886-2-2757-8888 #1563
Entrepreneurship
They celebrate entrepreneurs who lead the companies to embed innovation and embrace growth honoring their visions, leaderships, and extraordinary achievements. They present Taiwan entrepreneurship to the world through EY’s global network.
Ernst & Young Foundation / +886-2-2757-8888
Chuan Lin, chairman of TTY Biopharm, one of Taiwan’s leading domestic biomedical players, highlights his ambition to lead the local success story onto the global stage. Chuan goes on to…
Grace Yeh, president and founder of PharmaEngine, gives an update on the company’s recent growth and development of their second nanomedicine cancer treatment. Yeh goes on to explain the unique…
Researchers from Taiwan and the USA may have found a vaccine for the Middle East respiratory syndrome coronavirus (MERS-CoV) – a deadly emerging disease with a mortality rate of over…
Deputy Minister for Science and Technology on Taiwan Fong Chin Su gives his insights on innovation, cybersecurity, and the current state of one of the world’s most exciting biotech industries.…
Gou Jen Wang, the co-founder of Vida BioTechnology, and Bing Chen Gu, General Manager elaborate on how Vida BioTechnology provides added value to its customers by focusing on simplified use,…
Weichyun Wong, president of SCI Pharmtech, discusses the API manufacturer’s transition from a Swiss-owned affiliate to a Taiwanese company. He also talks technology and regulatory challenges, as well as what…
Eugene Huang, chairman, and Hua-Lin Wu, consultant of Blue Blood Biotech Corp., provide insightful information on BB-101, a protein proven to be efficient for wound healing, while sharing their vision…
Michael H.J. Lai, Founder of Body Organ Biomedical Corporation, discusses Ologen’s success as the first ever eye tissue repair product and highlights the importance of global exposure for Taiwan-based companies.…
Ken-Shwo Dai, president and CEO of Visgeneer, explains his biotech’s expertise in medtech, skincare, gene therapy and diagnostics, as well as his plans to take the company public. Can you…
Jassy Wang, CEO of MegaPro Biomedical, a nanomedicine development company specializing in developing nanoparticles and nanomicelles, discusses the evolving nanomedicine market in Taiwan and reveals the company’s plans for future…
Daniel Huang, CEO of Genomics Bioscience, Taiwan’s largest commercial genome sequencing company, and Chairman of Pharmigene, a global leader in the development and manufacturing of genetic tests, documents how he…
Yvonne Huang, VP of Aquavan, a company developing the most sophisticated high-tech green biotechnology platform for the extraction of plants, discusses their innovative technology and business scope while contributing to…
See our Cookie Privacy Policy Here